Clinical Trials Sponsored by Omnicell

Total 11 results

Hackensack Meridian Health
Omnicell

Completed

The IMPROVE Study-IMPact of a Regulated ADC System (IMPROVE)

Medication Compliance | Medication Administered in Error

United States
Micell Technologies

Completed

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)

Coronary Artery Disease

Belgium, Australia, New Zealand
Micell Technologies

Completed

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-II)

Coronary Artery Disease

New Zealand, Netherlands, United Kingdom, France, Belgium, Sweden
OriCell Therapeutics Co., Ltd.

Recruiting

Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC

Hepatocellular Carcinoma

China
OriCell Therapeutics Co., Ltd.

Enrolling by invitation

OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM

Relapsed and/or Refractory Multiple Myeloma

China
OriCell Therapeutics Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

Cardiovascular Diseases | Vascular Diseases | Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Immunoproliferative Disorders | Hematologic Diseases | Hemostatic Disorders | Hemorrhagic Disorders | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood...

United States
Zhejiang University
OriCell Therapeutics Co., Ltd.

Active, not recruiting

A Study of CAR-T Cells Targeting GPRC5D in the Treatment of r/r Multiple Myeloma

Multiple Myeloma

China
ECRI bv
Micell Technologies; Stentys

Completed

Study Comparing the MiStent SES Versus the XIENCE EES Stent (DESSOLVE III)

Coronary Stenosis

France, Germany, Netherlands, Poland
Micell Technologies
Cardialysis BV; ClinLogix. LLC

Unknown

Trial of MiStent Compared to Xience in Japan (DESSOLVEJ)

Coronary (Artery); Disease

Japan
Micell Technologies
Yale Cardiovascular Research Group; North American Science Associates Inc.; Baim...

Not yet recruiting

Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. (CRYSTAL)

Coronary Artery Disease
Micell Technologies
Hefei Life Science Medical Instruments Co. Ltd.; Giant Med-Pharma Services... and other collaborators

Unknown

Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) (DESSOLVE-C)

Coronary Heart Disease

China

Clinical Trials Sponsored by Omnicell

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations